SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1f82'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BU5_A_RBFA301_1
(PROTEIN (FLAVODOXIN))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 THR A 368
THR A 356
GLY A 273
ASP A 275
 None
 1.01A 1bu5A-1f82A:
undetectable		 1bu5A-1f82A:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_A_LPRA801_1
(ANGIOTENSIN
CONVERTING ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.92A 1j36A-1f82A:
undetectable		 1j36A-1f82A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_B_LPRB802_1
(ANGIOTENSIN
CONVERTING ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.92A 1j36B-1f82A:
undetectable		 1j36B-1f82A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_A_X8ZA801_1
(ANGIOTENSIN
CONVERTING ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.89A 1j37A-1f82A:
2.5		 1j37A-1f82A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_B_X8ZB802_1
(ANGIOTENSIN
CONVERTING ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.89A 1j37B-1f82A:
2.1		 1j37B-1f82A:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.90A 1o86A-1f82A:
undetectable		 1o86A-1f82A:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_A_LPRA705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.87A 2c6nA-1f82A:
2.6		 2c6nA-1f82A:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_B_LPRB705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.96A 2c6nB-1f82A:
undetectable		 2c6nB-1f82A:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2H79_A_T3A1_1
(THRA PROTEIN)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 ILE A  44
ILE A  45
ALA A  35
ALA A 155
ILE A 189
 None
 0.97A 2h79A-1f82A:
0.0		 2h79A-1f82A:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X8Z_A_X8ZA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.86A 2x8zA-1f82A:
undetectable		 2x8zA-1f82A:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.88A 2x91A-1f82A:
2.2		 2x91A-1f82A:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GWS_X_T3X500_1
(THYROID HORMONE
RECEPTOR BETA)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 ILE A  44
ILE A  45
ALA A  35
ALA A 155
ILE A 189
 None
 0.94A 3gwsX-1f82A:
0.0		 3gwsX-1f82A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KEC_B_HAEB271_1
(COLLAGENASE 3)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 HIS A 229
GLU A 230
HIS A 233
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
 0.14A 3kecB-1f82A:
undetectable		 3kecB-1f82A:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_A_1N1A2000_1
(P38A)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 ILE A  18
MET A  20
ARG A 149
ILE A  13
ALA A  35
 None
 1.10A 3ohtA-1f82A:
0.0
3ohtB-1f82A:
0.0		 3ohtA-1f82A:
22.39
3ohtB-1f82A:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R9V_B_DXCB1_0
(INVASIN IPAD)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 ILE A 241
LEU A 351
VAL A 330
SER A 338
 None
 0.89A 3r9vA-1f82A:
0.0
3r9vB-1f82A:
0.0		 3r9vA-1f82A:
20.79
3r9vB-1f82A:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQW_I_ACHI323_0
(ELIC PENTAMERIC
LIGAND GATED ION
CHANNEL FROM ERWINIA
CHRYSANTHEMI)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 8 ILE A 366
TYR A 391
LEU A 385
PHE A 397
 None
 0.95A 3rqwI-1f82A:
0.0
3rqwJ-1f82A:
0.0		 3rqwI-1f82A:
19.86
3rqwJ-1f82A:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TMZ_A_06XA503_1
(CYTOCHROME P450 2B4)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 11 ILE A  42
ILE A  98
PHE A 194
ILE A 159
VAL A 234
 None
 1.01A 3tmzA-1f82A:
0.0		 3tmzA-1f82A:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TMZ_A_06XA503_1
(CYTOCHROME P450 2B4)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 11 ILE A  98
PHE A 194
ILE A 159
ALA A 224
VAL A 234
 None
 1.04A 3tmzA-1f82A:
0.0		 3tmzA-1f82A:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WXO_A_NIZA804_1
(CATALASE-PEROXIDASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 ASN A 138
GLU A  22
ARG A  27
 None
 0.91A 3wxoA-1f82A:
0.0		 3wxoA-1f82A:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_A_0LIA1000_2
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 9 MET A  91
ILE A  38
ILE A  44
TYR A  33
ILE A  42
 None
 1.10A 3zosA-1f82A:
undetectable		 3zosA-1f82A:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_A_ZPCA1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 PHE A 154
VAL A 135
ARG A  27
ILE A 132
 None
 1.00A 4a97E-1f82A:
0.0		 4a97E-1f82A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_D_ZPCD1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 8 PHE A 154
VAL A 135
ARG A  27
ILE A 132
 None
 0.92A 4a97C-1f82A:
0.0		 4a97C-1f82A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_E_ZPCE1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 8 PHE A 154
VAL A 135
ARG A  27
ILE A 132
 None
 0.99A 4a97D-1f82A:
0.0		 4a97D-1f82A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_H_ZPCH1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 8 PHE A 154
VAL A 135
ARG A  27
ILE A 132
 None
 1.02A 4a97G-1f82A:
0.0		 4a97G-1f82A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_I_ZPCI1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 PHE A 154
VAL A 135
ARG A  27
ILE A 132
 None
 1.08A 4a97H-1f82A:
0.0		 4a97H-1f82A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_J_ZPCJ1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 8 PHE A 154
VAL A 135
ARG A  27
ILE A 132
 None
 1.05A 4a97I-1f82A:
0.0		 4a97I-1f82A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C2P_A_X8ZA709_1
(ANGIOTENSIN-CONVERTI
NG ENZYME)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.89A 4c2pA-1f82A:
2.1		 4c2pA-1f82A:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CEV_A_GAIA407_0
(PROTEIN (ARGINASE))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 ARG A 122
HIS A 179
GLU A 184
ASP A 120
 None
 1.26A 4cevA-1f82A:
undetectable
4cevB-1f82A:
undetectable		 4cevA-1f82A:
20.62
4cevB-1f82A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CEV_B_GAIB408_0
(PROTEIN (ARGINASE))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 5 ARG A 122
HIS A 179
GLU A 184
ASP A 120
 None
 1.27A 4cevB-1f82A:
0.0
4cevC-1f82A:
0.0		 4cevB-1f82A:
20.62
4cevC-1f82A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CEV_C_GAIC409_0
(PROTEIN (ARGINASE))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 ASP A 120
ARG A 122
HIS A 179
GLU A 184
 None
 1.25A 4cevA-1f82A:
undetectable
4cevC-1f82A:
undetectable		 4cevA-1f82A:
20.62
4cevC-1f82A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CEV_D_GAID410_0
(PROTEIN (ARGINASE))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 ARG A 122
HIS A 179
GLU A 184
ASP A 120
 None
 1.28A 4cevD-1f82A:
undetectable
4cevE-1f82A:
undetectable		 4cevD-1f82A:
20.62
4cevE-1f82A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CEV_F_GAIF411_0
(PROTEIN (ARGINASE))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 ARG A 122
HIS A 179
GLU A 184
ASP A 120
 None
 1.26A 4cevE-1f82A:
undetectable
4cevF-1f82A:
0.0		 4cevE-1f82A:
20.62
4cevF-1f82A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CEV_F_GAIF412_0
(PROTEIN (ARGINASE))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 5 ASP A 120
ARG A 122
HIS A 179
GLU A 184
 None
 1.24A 4cevD-1f82A:
0.7
4cevF-1f82A:
0.0		 4cevD-1f82A:
20.62
4cevF-1f82A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DR2_A_PARA1609_1
(16S RRNA
30S RIBOSOMAL
PROTEIN S9
30S RIBOSOMAL
PROTEIN S10)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 TYR A  72
ARG A  67
SER A 424
 None
 0.93A 4dr2I-1f82A:
0.3
4dr2J-1f82A:
undetectable		 4dr2I-1f82A:
14.11
4dr2J-1f82A:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_A_NCTA501_1
(CYTOCHROME P450 2A6)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 PHE A  25
ASN A 178
GLY A 175
ILE A 172
 None
 0.78A 4ejjA-1f82A:
0.0		 4ejjA-1f82A:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LF7_A_PARA1817_1
(16S RRNA
RIBOSOMAL PROTEIN S9
RIBOSOMAL PROTEIN
S10)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 TYR A  72
ARG A  67
SER A 424
 None
 0.84A 4lf7I-1f82A:
0.0
4lf7J-1f82A:
0.0		 4lf7I-1f82A:
14.11
4lf7J-1f82A:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LF8_A_PARA1817_1
(16S RRNA
RIBOSOMAL PROTEIN S9
RIBOSOMAL PROTEIN
S10)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 TYR A  72
ARG A  67
SER A 424
 None
 0.84A 4lf8I-1f82A:
0.0
4lf8J-1f82A:
0.0		 4lf8I-1f82A:
14.11
4lf8J-1f82A:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LV9_A_20JA601_1
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 8 PHE A 271
ASP A 275
SER A 374
ARG A 369
 None
 1.06A 4lv9A-1f82A:
0.0
4lv9B-1f82A:
0.0		 4lv9A-1f82A:
22.43
4lv9B-1f82A:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LV9_B_20JB601_1
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 PHE A 271
ASP A 275
SER A 374
ARG A 369
 None
 1.05A 4lv9A-1f82A:
undetectable
4lv9B-1f82A:
undetectable		 4lv9A-1f82A:
22.43
4lv9B-1f82A:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LV9_B_20JB601_1
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 TYR A 372
ASP A 275
SER A 374
ARG A 369
 None
 1.25A 4lv9A-1f82A:
undetectable
4lv9B-1f82A:
undetectable		 4lv9A-1f82A:
22.43
4lv9B-1f82A:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OTW_A_DB8A1101_2
(RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 LEU A  88
LEU A 385
ASN A  96
 None
 0.66A 4otwA-1f82A:
undetectable		 4otwA-1f82A:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R7L_A_SHHA709_1
(LEUKOTRIENE A-4
HYDROLASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 267
TYR A 372
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-2.1A)
None
 0.45A 4r7lA-1f82A:
3.4		 4r7lA-1f82A:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XR4_B_AG2B511_1
(HOMOSPERMIDINE
SYNTHASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 VAL A 135
PHE A 128
ARG A 301
 None
 0.92A 4xr4B-1f82A:
undetectable		 4xr4B-1f82A:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YJI_A_TYLA502_1
(ARYL ACYLAMIDASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 7 LEU A 351
GLY A 240
GLY A 185
ILE A 298
 None
 0.74A 4yjiA-1f82A:
undetectable		 4yjiA-1f82A:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JW1_B_CELB602_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 VAL A 205
VAL A 201
SER A 221
ILE A 382
 None
 1.07A 5jw1B-1f82A:
0.0		 5jw1B-1f82A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVM_A_PFLA510_1
(PROTON-GATED ION
CHANNEL)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 9 ALA A 262
ILE A 263
ILE A 279
ALA A 265
LEU A 268
 None
 1.11A 5mvmA-1f82A:
0.0
5mvmE-1f82A:
0.0		 5mvmA-1f82A:
10.90
5mvmE-1f82A:
10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5PAH_A_LDPA600_1
(PHENYLALANINE
4-MONOOXYGENASE)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 4 HIS A 233
HIS A 229
TYR A 372
GLU A 267
 ZN  A 500 (-3.3A)
ZN  A 500 (-3.2A)
None
ZN  A 500 (-2.1A)
 1.30A 5pahA-1f82A:
undetectable		 5pahA-1f82A:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_A_PCFA1801_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 ILE A  92
ILE A 158
LEU A 157
PHE A  51
 None
 1.07A 5vkqA-1f82A:
0.0
5vkqB-1f82A:
0.0		 5vkqA-1f82A:
12.88
5vkqB-1f82A:
12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_D_PCFD1807_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 PHE A  51
ILE A  92
ILE A 158
LEU A 157
 None
 1.07A 5vkqA-1f82A:
0.0
5vkqD-1f82A:
0.0		 5vkqA-1f82A:
12.88
5vkqD-1f82A:
12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BER_A_DVAA2_0
(E(DVA)DP(DGL)(DHI)(D
PR)N(DAL)(DPR))		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		3 / 3 GLU A 267
ASP A 275
PRO A 276
 ZN  A 500 (-2.1A)
None
None
 0.68A 6berA-1f82A:
undetectable		 6berA-1f82A:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FGD_A_ACTA824_0
(GEPHYRIN)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 4 LEU A 385
ASP A 222
PRO A 223
ARG A  97
 None
 1.02A 6fgdA-1f82A:
undetectable		 6fgdA-1f82A:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_B_STIB602_1
(TYROSINE-PROTEIN
KINASE ABL1)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		4 / 6 LEU A 103
TYR A 364
VAL A 205
PHE A 355
 None
 1.02A 6hd4B-1f82A:
undetectable		 6hd4B-1f82A:
11.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6IFT_A_SAMA301_0
(RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE A)		 1f82 BOTULINUM NEUROTOXIN
TYPE B
(Clostridium
botulinum) 		5 / 12 ILE A 158
GLY A 188
ILE A 172
ASP A 173
PRO A  24
 None
 1.05A 6iftA-1f82A:
undetectable		 6iftA-1f82A:
21.23